- Home
- SR vs KYMR Comparison
SR vs KYMR Comparison
Compare SR & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SR | KYMR |
|---|---|---|
| Founded | 1857 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.7B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SR | KYMR |
|---|---|---|
| Price | $82.47 | $66.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 19 |
| Target Price | ★ $85.91 | $69.58 |
| AVG Volume (30 Days) | 432.9K | ★ 698.8K |
| Earning Date | 11-14-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.81% | N/A |
| EPS Growth | ★ 4.30 | N/A |
| EPS | ★ 4.37 | N/A |
| Revenue | ★ $2,476,400,000.00 | $43,735,000.00 |
| Revenue This Year | $13.96 | $20.81 |
| Revenue Next Year | $9.43 | N/A |
| P/E Ratio | $18.86 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $64.44 | $19.45 |
| 52 Week High | $91.11 | $68.80 |
Technical Indicators
Market Signals| Indicator | SR | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 36.02 | 60.17 |
| Support Level | $84.78 | $63.69 |
| Resistance Level | $88.66 | $68.78 |
| Average True Range (ATR) | 1.83 | 2.85 |
| MACD | -0.70 | -0.20 |
| Stochastic Oscillator | 4.59 | 63.67 |
Price Performance
Historical ComparisonAbout SR Spire Inc.
Spire Inc. is the holding company for Spire Missouri, Spire Alabama, other gas utilities, and gas-related businesses, focused on growing organically, investing in infrastructure, and advancing through innovation. Its three segments are Gas Utility, Gas Marketing, and Midstream. The Gas Utility segment is the core business and includes Spire Missouri, Spire Alabama, and Spire EnergySouth. The Gas Marketing segment includes Spire Marketing, which provides non-regulated natural gas services across the U.S. The Midstream segment includes Spire Storage, Spire STL Pipeline, and Spire MoGas Pipeline. The majority of revenue comes from Gas Utility.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.